News

Ovagen, a pioneering peptide bioregulator, has emerged as a significant advancement in liver health management. Developed to correct pathological changes in the liver, Ovagen® offers both protective and restorative effects on liver cells. This peptide complex contains essential amino acids that contribute to the normalization of liver function and the gastrointestinal tract.

A recent clinical study has demonstrated Ovagen's effectiveness in both the prevention and treatment of various liver conditions. These include hepatitis of different etiologies, complications from radiation and chemotherapy, side effects from antibiotics and other drugs, as well as the adverse effects of environmental toxins and malnutrition. Ovagen also supports liver function in elderly patients.

Patients with chronic persistent hepatitis and chronic liver disease have reported significant improvements following Ovagen treatment. These improvements include the disappearance of weakness, increased appetite and efficiency, reduced diarrheal illness, and diminished pain intensity. Importantly, Ovagen has shown excellent tolerance among patients, with no identified side effects, complications, contraindications, or drug dependence.